Abstract:Background Melanoma is a malignant tumor of melanocytes, and the incidence has increased faster than any other cancer over the past half century. Most primary melanoma can be cured by local excision, but metastatic melanoma has a poor prognosis. Cutaneous melanoma (CM) is prone to metastasis, so the research on the mechanism of melanoma occurrence and metastasis will be beneficial to diagnose early, improve treatment, and prolong life survival. In this study, we compared the gene expression of normal skin (N), primary cutaneous melanoma (PM) and metastatic cutaneous melanoma (MM) in the Gene Expression Omnibus (GEO) database. Then we identified the key genes and molecular pathways that may be involved in the development and metastasis of cutaneous melanoma, thus to discover potential markers or therapeutic targets. Methods Three gene expression profiles ( GSE7553 , GSE15605 and GSE46517 ) were downloaded from the GEO database, which contained 225 tissue samples. R software identified the differentially expressed genes (DEGs) between pairs of N, PM and MM samples in the three sets of data. Subsequently, we analyzed the gene ontology (GO) function and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway of the DEGs, and constructed a protein-protein interaction (PPI) network. MCODE was used to seek the most important modules in PPI network, and then the GO function and KEGG pathway of them were analyzed. Finally, the hub genes were calculated by the cytoHubba in Cytoscape software. The Cancer Genome Atlas (TCGA) data were analyzed using UALCAN and GEPIA to validate the hub genes and analyze the prognosis of patients. Results A total of 134, 317 and 147 DEGs were identified between N, PM and MM in pair. GO functions and KEGG pathways analysis results showed that the upregulated DEGs mainly concentrated in cell division, spindle microtubule, protein kinase activity and the pathway of transcriptional misregulation in cancer. The downregulated DEGs occurred in epidermis development, extracellular exosome, structural molecule activity, metabolic pathways and p53 signaling pathway. The PPI network obtained the most important module, whose GO function and KEGG pathway were enriched in oxidoreductase activity, cell division, cell exosomes, protein binding, structural molecule activity, and metabolic pathways. 14, 18 and 18 DEGs were identified respectively as the hub genes between N, PM and MM, and TCGA data confirmed the expression differences of hub genes. In addition, the overall survival curve of hub genes showed that the differences in these genes may lead to a significant decrease in overall survival of melanoma patients. Conclusions In this study, several hub genes were found from normal skin, primary melanoma and metastatic melanoma samples. These hub genes may play an important role in the production, invasion, recurrence or death of CM, and may provide new ideas and potential targets for its diagnosis or treatment.

Novel MicroRNA Biomarkers, <i>miR-142-5p</i>, <i>miR-550a</i>, <i>miR-1826</i>, and <i>miR-1201</i>, Were Identified for Primary Melanoma

Stage-specific prognostic biomarkers in melanoma.

Identification of a Five-Mirna Signature Predicting Survival in Cutaneous Melanoma Cancer Patients.

Bioinformatics Analysis Identifies MicroRNAs and Target Genes Associated with Prognosis in Patients with Melanoma

A Study on the Expression of miRNA Gene Subtypes in Tumoral vs. Benign Nevi

Bioinformatics Analysis to Identify the Critical Genes, Micrornas and Long Noncoding RNAs in Melanoma

Association of miR-146a-5p and miR-21-5p with Prognostic Features in Melanomas

Identification of Metastasis-Associated MicroRNAs in Metastatic Melanoma by Mirna Expression Profile and Experimental Validation

Novel diagnosis- and progression-related microRNA signatures in melanoma

The Expression of miR-211-5p in Sentinel Lymph Node Metastases of Malignant Melanoma Is a Potential Marker for Poor Prognosis

Discovery and Validation of a Metastasis-Related Prognostic and Diagnostic Biomarker for Melanoma Based on Single Cell and Gene Expression Datasets.

Identification of Microrna Biomarkers in the Blood of Breast Cancer Patients Based on Microrna Profiling.

633 Serum Mir-16: A Potential Biomarker for Predicting Melanoma Prognosis

Screening Genes Associated with Melanoma Using a Combined Analysis of Mrna and Methylation Microarray

Identification of Differentially Expressed Micrornas in Metastatic Melanoma Using Next-Generation Sequencing Technology

Identification of Differentially Expressed Micrornas and the Potential of Microrna-455-3p As a Novel Prognostic Biomarker in Glioma

Identification of Epithelial–Mesenchymal Transition-Related Prognostic lncRNAs Biomarkers Associated With Melanoma Microenvironment

Identification of lncRNA-mRNA Regulatory Module to Explore the Pathogenesis and Prognosis of Melanoma

Serum Exosomal Micrornas As Potent Circulating Biomarkers for Melanoma.

Crucial Micrornas and Genes of Human Primary Breast Cancer Explored by Microrna-Mrna Integrated Analysis

Comprehensive analysis and identification of key genes and signaling pathways in the occurrence and metastasis of cutaneous melanoma